Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P21
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-41.20%
2024110.96%
2023-44.07%
2022-41.97%
2021-36.58%
2020378.82%
2019-18.62%
201816.96%
2017-16.01%
2016101.74%